Healthy men and women with good cholesterol levels could significantly reduce their risk of heart disease by taking cholesterol-lowering drugs, better known as statins, according to a study released at the American Heart Association meetings in November.
A researcher unveiled on Monday the results of a failed Pfizer Inc. study showing that an experimental but dangerous cholesterol drug offers medical benefits too significant to be ignored.
Cholesterol-lowering statins - which include the world's top-selling drug, Lipitor - and other drugs called fibrates can lower the risk of developing a common form of nerve damage in diabetics that often results in amputations, according to study results unveiled Friday.
An experimental drug from AtheroGenics and its partner AstraZeneca failed a late-stage clinical trial and is not considered an effective treatment in reducing heart disease, the companies said.
Getting cheaper prescription drugs from Canada just got easier. The Department of Homeland Security won't be confiscating medicine shipped from Canada to the United States. But before you go online, we're going to tell you what you need to know about this policy change.
Merck and Schering-Plough announced a study on Sunday showing that their combination drug Vytorin is better at lowering cholesterol than competing drug Crestor from AstraZeneca.
Vytorin, a relatively new cholesterol-blocking drug from Merck and Schering-Plough, has outpaced sales of a blockbuster rival, according to a report Monday from Friedman, Billings, Ramsey & Co.
Healthy men and women with good cholesterol levels could significantly reduce their risk of heart disease by taking cholesterol-lowering drugs, better known as statins, according to a study released at the American Heart Association meetings in November.
A researcher unveiled on Monday the results of a failed Pfizer Inc. study showing that an experimental but dangerous cholesterol drug offers medical benefits too significant to be ignored.
Cholesterol-lowering statins - which include the world's top-selling drug, Lipitor - and other drugs called fibrates can lower the risk of developing a common form of nerve damage in diabetics that often results in amputations, according to study results unveiled Friday.
An experimental drug from AtheroGenics and its partner AstraZeneca failed a late-stage clinical trial and is not considered an effective treatment in reducing heart disease, the companies said.
Getting cheaper prescription drugs from Canada just got easier. The Department of Homeland Security won't be confiscating medicine shipped from Canada to the United States. But before you go online, we're going to tell you what you need to know about this policy change.
Merck and Schering-Plough announced a study on Sunday showing that their combination drug Vytorin is better at lowering cholesterol than competing drug Crestor from AstraZeneca.
Vytorin, a relatively new cholesterol-blocking drug from Merck and Schering-Plough, has outpaced sales of a blockbuster rival, according to a report Monday from Friedman, Billings, Ramsey & Co.
Drugmakers have cut television ad spending by 10 percent in the first quarter from a year ago, the sharpest decline in two years, a newspaper said Tuesday.
When Merck yanked the arthritis wonder drug Vioxx off shelves this fall, it not only devastated the company's stock and reputation, it raised fears about the safety of every big new drug. After all...
Will one statin a day keep the doctor away? That's the question Americans and their doctors are asking as medical research suggests the drugs do far more than lower cholesterol. The buzz started ...
The share of new prescriptions written for the cholesterol-lowering drug Lipitor surged during the past week as the Pfizer Inc. (PFE) blockbuster got a boost from a big study showing it was better than Bristol-Myers Squibb Co.'s ( BMY) Pravachol in preventing heart attacks, Thursday's Wall Street Journal reported.
Actuaries, not economists, are the truly dismal scientists. Consider some actuarial projections about the graying America of 2050: One in 26 of us will have Alzheimer's disease, compared with one i...
Move over, cholesterol. The latest heart-attack culprit is C-reactive protein (CRP). CRP, which is produced when arteries are inflamed, was nailed in a groundbreaking November New England Journal o...
The page you requested cannot be found. The page you are looking for might have been removed, had its name changed, or is temporarily unavailable.
Please try the following:
• If you typed the page address in the Address bar, make sure that it is spelled correctly.
• Open the edition.cnn.com home page and look for links to the information you want.
• Use the navigation bar above to find the link you are looking for.
• Click the Back button to try another link.
• Enter a term in the search form below to look for information on CNN sites or the Internet.
Video
